NEW YORK--(BUSINESS WIRE)--InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), today announced that its RESPeRATE® hypertension treatment device, clinically-proven to significantly lower blood pressure, will be available at Kerr Drug, a leading innovative retail community pharmacy in the United States.
